J I Weitz Selected Research

J I Weitz Research Topics

Disease

12	Hemorrhage 01/2020 - 06/2000
11	Thrombosis (Thrombus) 06/2015 - 04/2000
10	Venous Thromboembolism 01/2020 - 11/2000
6	Myocardial Infarction 01/2017 - 03/2000
4	Neoplasms (Cancer) 01/2020 - 12/2007
4	Unstable Angina 03/2003 - 03/2000
3	Atrial Fibrillation 03/2015 - 08/2005
3	Acute Coronary Syndrome 11/2002 - 06/2000
3	Venous Thrombosis (Deep-Vein Thrombosis) 09/2001 - 03/2001
2	Ischemic Stroke 10/2018 - 12/2017
2	Ischemia 03/2003 - 02/2001
2	Thrombocytopenia (Thrombopenia) 02/2001 - 12/2000
2	Rupture 12/2000 - 03/2000
1	Urogenital Neoplasms 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Stroke (Strokes) 10/2018
1	Renal Insufficiency (Renal Failure) 12/2017
1	Pulmonary Embolism 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2015
1	Drug-Related Side Effects and Adverse Reactions 11/2014
1	Healthcare-Associated Pneumonia 11/2014
1	Infections 11/2014
1	Heart Diseases (Heart Disease) 05/2013
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Thromboembolism 08/2005
1	Pathologic Constriction (Stenosis) 01/2005
1	Sepsis (Septicemia) 09/2001
1	Inflammation (Inflammations) 09/2001
1	Death (Near-Death Experience) 03/2000
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2000

Drug/Important Bio-Agent (IBA)

11	AnticoagulantsIBA 01/2018 - 04/2000
11	Heparin (Liquaemin)FDA LinkGeneric 08/2014 - 03/2000
5	FibrinIBA 06/2012 - 03/2000
4	Thrombin FDA Link 06/2012 - 04/2000
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2002 - 03/2000
3	Dabigatran FDA Link 12/2017 - 07/2014
3	fibrin fragment D (D-dimer)IBA 10/2016 - 07/2001
3	Warfarin (Coumadin)FDA LinkGeneric 12/2015 - 05/2004
3	HirudinsIBA 03/2003 - 09/2000
2	edoxabanIBA 01/2020 - 01/2020
2	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2018 - 03/2001
2	Pharmaceutical PreparationsIBA 12/2017 - 02/2001
2	AntithrombinsIBA 08/2005 - 03/2003
2	Clopidogrel (Plavix)FDA Link 11/2002 - 03/2000
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2001 - 06/2000
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2018
1	Prothrombin (Factor II)IBA 01/2018
1	RivaroxabanIBA 01/2018
1	Tranexamic Acid (AMCA)FDA Link 01/2018
1	Factor Xa InhibitorsIBA 01/2018
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2015
1	apixabanIBA 12/2015
1	Biocompatible Materials (Biomaterials)IBA 06/2015
1	Adenosine Diphosphate (ADP)IBA 08/2014
1	PhosphatidylserinesIBA 06/2012
1	Annexin A5IBA 06/2012
1	Thromboplastin (Tissue Factor)IBA 12/2007
1	ximelagatran (Exanta)IBA 08/2005
1	Fondaparinux (Arixtra)FDA Link 08/2005
1	idraparinuxIBA 08/2005
1	thiamine triphosphorate (TTP)IBA 01/2005
1	Heparinoids (Heparinoid)IBA 01/2005
1	melagatranIBA 03/2003
1	EndotoxinsIBA 09/2001
1	prolyl-proline (Pro-Pro)IBA 09/2001
1	Factor X (Stuart Factor)IBA 08/2001
1	Heparin Cofactor IIIBA 08/2001
1	Factor IXa (Coagulation Factor IXa)IBA 08/2001
1	Streptokinase FDA Link 08/2001
1	VasofluxIBA 08/2001
1	Plasminogen Activator Inhibitor 1IBA 03/2001
1	Serum GlobulinsIBA 03/2001
1	bivalirudin (Angiomax)FDA Link 12/2000
1	Platelet Factor 4IBA 12/2000
1	Nucleotide AptamersIBA 04/2000
1	Biotin (Vitamin H)FDA Link 04/2000
1	ThienopyridinesIBA 03/2000
1	Ticlopidine (Ticlid)FDA LinkGeneric 03/2000

Therapy/Procedure

8	Therapeutics 01/2020 - 03/2000
3	Catheters 06/2015 - 07/2014
2	Thrombolytic Therapy 10/2018 - 12/2017
2	Percutaneous Coronary Intervention 05/2013 - 12/2000
1	Thrombectomy 10/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017
1	Stents 06/2015
1	Electric Countershock (Cardioversion) 05/2013
1	Lasers (Laser) 06/2012
1	Orthopedic Procedures 08/2005
1	Aftercare (After-Treatment) 05/2004
1	Duration of Therapy 05/2004
1	Ligation 09/2001
1	Hirudin Therapy 02/2001